International Journal of Drug Policy
Volume 17, Issue 2 , Pages 73-82, March 2006

The establishment of North America's first state sanctioned supervised injection facility: A case study in culture change

  • Dan Small

      Affiliations

    • Portland Hotel Society, Vancouver, Canada
  • ,
  • Anita Palepu

      Affiliations

    • Department of Medicine, University of British Columbia, Canada
  • ,
  • Mark W. Tyndall

      Affiliations

    • Department of Medicine, University of British Columbia, Canada
    • British Columbia Centre for Excellence in HIV/AIDS, Canada
    • Corresponding Author InformationCorresponding author at: BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6. Tel.: +1 604 806 8535; fax: +1 604 806 9044.

Received 4 April 2005; received in revised form 29 August 2005; accepted 30 August 2005.

Abstract 

The serious adverse health consequences associated with illicit drug use in Vancouver has brought international attention to the city. It is now widely recognized that innovative and bold strategies are required to confront epidemics of drug overdose, HIV and Hepatitis C infections, and injection-related bacterial infections. The establishment of North America's first supervised injection facility (SIF) required a major cultural shift in the way drug addiction is viewed. The story behind the SIF in Vancouver is a complex and interconnected series of events brought about by the activities of advocates, peers, community agencies, politicians, journalists, academics and other key players to bring about social change. The aim of this narrative is to highlight the ideas, processes and historical events that contributed to a cultural transformation that was critical to opening the SIF in Vancouver. By doing this, we hope to encourage other communities to take the bold steps necessary to reduce the devastating health and social consequences of injection drug use.

Keywords: Injection drug use, Supervised injection facilities, Harm reduction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(05)00203-3

doi:10.1016/j.drugpo.2005.08.004

International Journal of Drug Policy
Volume 17, Issue 2 , Pages 73-82, March 2006